Bromomethane

Bromomethane

SCHEMBL3169191

CBr.O=C(O)C(O)(c1ccc(F)c(Cl)c1)c1ccc(F)c(Cl)c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.46
CYP2D6 P10635 1/20 0.46
HIF1A Q16665 1/20 0.46
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HTT P42858 3/20 0.41
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
SLC2A1 P11166 1/20 0.38
RPA1 P27694 1/20 0.38
KDM4E B2RXH2 1/20 0.37
KMO O15229 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3173667 0.95 CYP2C9 (0.46) CYP2C9CYP2D6HIF1AAKR1C3AKR1C2
Bromomethane SCHEMBL3178733 0.87 CYP2C9 (0.46) CYP2C9CYP2D6HIF1AAKR1C3AKR1C2
Bromomethane SCHEMBL3163376 0.84 CYP2C9 (0.50) CYP2C9CYP2D6HIF1ANPC1RAB9A
Bromomethane SCHEMBL209035 0.84 KCNN4 (0.47) CYP2C9CYP2D6HIF1AAKR1C3AKR1C2
SCHEMBL3179071 0.81 CYP2C9 (0.46) CYP2C9CYP2D6HIF1AAKR1C3AKR1C2
SCHEMBL1626272 0.79 AKR1C3 (0.63) CYP2C9AKR1C3AKR1C2NPC1RAB9A
SCHEMBL3172917 0.79 HTT (0.44) NPC1RAB9AHTTTSHRALDH1A1
SCHEMBL3168786 0.78 CYP2C9 (0.50) CYP2C9CYP2D6HIF1ANPC1RAB9A
Bromomethane SCHEMBL222144 0.78 CYP2C9 (0.60) CYP2C9CYP2D6HIF1ANPC1RAB9A
SCHEMBL523840 0.78 KCNN4 (0.51) CYP2C9CYP2D6HIF1AAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652138-B2 Anticholinergics, processes for preparing them and pharmaceutical composition containing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-01-26 US claimed
US-7652138-B2 Anticholinergics, processes for preparing them and pharmaceutical composition containing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-01-26 US disclosed
US-20050054664-A1 Anticholinergics, processes for preparing them and pharmaceutical composition containing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-03-10 US disclosed
US-6852728-B2 Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-02-08 US disclosed
US-20020119991-A1 Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020119991-A1 Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them CHRM1, CHRM3, CHRM2 CYP2C9 368/4885CYP2D6 162/4885HIF1A 3172/4885
US-20050054664-A1 Anticholinergics, processes for preparing them and pharmaceutical composition containing them CHRM1, CHRM3, CHRM2 CYP2C9 162/4885CYP2D6 147/4885HIF1A 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.